Meng, Q.; Luo, L.; Lei, M.; Chen, Z.; Sun, Y.; Chen, X.; Zhai, Z.; Zhang, Y.; Cao, J.; Su, Z.;
et al. Inhibition of FGFR2 Signaling by Cynaroside Attenuates Liver Fibrosis. Pharmaceuticals 2023, 16, 548.
https://doi.org/10.3390/ph16040548
AMA Style
Meng Q, Luo L, Lei M, Chen Z, Sun Y, Chen X, Zhai Z, Zhang Y, Cao J, Su Z,
et al. Inhibition of FGFR2 Signaling by Cynaroside Attenuates Liver Fibrosis. Pharmaceuticals. 2023; 16(4):548.
https://doi.org/10.3390/ph16040548
Chicago/Turabian Style
Meng, Qilin, Lin Luo, Minghua Lei, Zhiqi Chen, Yuanmeng Sun, Xue Chen, Zhaodong Zhai, Yibo Zhang, Jieqiong Cao, Zijian Su,
and et al. 2023. "Inhibition of FGFR2 Signaling by Cynaroside Attenuates Liver Fibrosis" Pharmaceuticals 16, no. 4: 548.
https://doi.org/10.3390/ph16040548
APA Style
Meng, Q., Luo, L., Lei, M., Chen, Z., Sun, Y., Chen, X., Zhai, Z., Zhang, Y., Cao, J., Su, Z., Li, F., Li, J., Hong, A., & Chen, X.
(2023). Inhibition of FGFR2 Signaling by Cynaroside Attenuates Liver Fibrosis. Pharmaceuticals, 16(4), 548.
https://doi.org/10.3390/ph16040548